Alfortville, France

Hervé Poras

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hervé Poras. Retrieved from https://idiyas.com/inventor/hervandeacute-poras

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hervé Poras: Innovator in Amino Acid Derivatives

Introduction

Hervé Poras is a notable inventor based in Alfortville, France. He has made significant contributions to the field of chemistry, particularly in the development of amino acid derivatives. His work has implications for various medical applications, showcasing the importance of innovation in scientific research.

Latest Patents

Hervé Poras holds a patent for "Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors." This patent highlights his focus on creating compounds that can potentially be used in therapeutic settings, addressing critical health issues.

Career Highlights

Throughout his career, Hervé Poras has demonstrated a commitment to advancing scientific knowledge. His innovative approach to amino acid derivatives has positioned him as a key figure in his field. His work not only contributes to academic research but also has practical applications in medicine.

Collaborations

Hervé Poras has collaborated with esteemed colleagues such as Bernard P. Roques and Marie-Claude Fournie-Zaluski. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Hervé Poras is a distinguished inventor whose work on amino acid derivatives has the potential to influence medical treatments. His contributions to science exemplify the vital role of innovation in addressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…